Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Legend Biotech has raised $226.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Legend Biotech's investors include RA Capital Management, Vivo Capital, Lilly Asia Ventures, Hudson Bay Capital Management, Johnson & Johnson Robotics and Digital Solutions.
Legend Biotech is headquartered in Piscataway, United States.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Legend Biotech is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Legend Biotech — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/legend-biotech. Accessed July 20, 2026.
VCBacked. (2026). Legend Biotech — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/legend-biotech
{{cite web |title=Legend Biotech — Funding & Investors |url=https://www.vcbacked.co/company/legend-biotech |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated